These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9577285)

  • 21. [Reference ranges for M-mode echocardiographic measurements within seven days after birth in preterm infants].
    Lu DF; Liu YF; Tong XM; Zhang H; Shi S; Zhang YH
    Zhonghua Er Ke Za Zhi; 2020 Dec; 58(12):989-994. PubMed ID: 33256321
    [No Abstract]   [Full Text] [Related]  

  • 22. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease.
    Murphy BP; Inder TE; Huppi PS; Warfield S; Zientara GP; Kikinis R; Jolesz FA; Volpe JJ
    Pediatrics; 2001 Feb; 107(2):217-21. PubMed ID: 11158449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody response to accelerated Hib immunisation in preterm infants receiving dexamethasone for chronic lung disease.
    Robinson MJ; Campbell F; Powell P; Sims D; Thornton C
    Arch Dis Child Fetal Neonatal Ed; 1999 Jan; 80(1):F69-71. PubMed ID: 10325817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiorespiratory adaptation to low-dose dexamethasone for lung disease in extremely preterm infants: A prospective echocardiographic study.
    Sehgal A; Nold MF; Roberts CT; Menahem S
    J Physiol; 2022 Oct; 600(19):4361-4373. PubMed ID: 36068678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dexamethasone on blood pressure--relationship to postnatal age.
    Emery EF; Greenough A
    Eur J Pediatr; 1992 May; 151(5):364-6. PubMed ID: 1396892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.
    Stark AR; Carlo WA; Tyson JE; Papile LA; Wright LL; Shankaran S; Donovan EF; Oh W; Bauer CR; Saha S; Poole WK; Stoll BJ;
    N Engl J Med; 2001 Jan; 344(2):95-101. PubMed ID: 11150359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Qualitative assessment of general movements in high-risk preterm infants with chronic lung disease requiring dexamethasone therapy.
    Bos AF; Martijn A; van Asperen RM; Hadders-Algra M; Okken A; Prechtl HF
    J Pediatr; 1998 Feb; 132(2):300-6. PubMed ID: 9506645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on Postnatal Steroids.
    Halliday HL
    Neonatology; 2017; 111(4):415-422. PubMed ID: 28538237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reference ranges for cardiac dimensions and blood flow velocity in preterm infants.
    Skelton R; Gill AB; Parsons JM
    Heart; 1998 Sep; 80(3):281-5. PubMed ID: 9875089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postnatal hydrocortisone treatment for chronic lung disease in the preterm newborn and long-term neurodevelopmental follow-up.
    Rademaker KJ; de Vries LS; Uiterwaal CS; Groenendaal F; Grobbee DE; van Bel F
    Arch Dis Child Fetal Neonatal Ed; 2008 Jan; 93(1):F58-63. PubMed ID: 17848504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertrophic Cardiomyopathy After a Single Dose of Dexamethasone in a Preterm Infant.
    Kale Y; Aydemir O; Ceylan O; Bas AY; Demirel N
    Pediatr Neonatol; 2015 Aug; 56(4):268-70. PubMed ID: 23639746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticosteroids and chronic lung disease in extremely immature infants: a dilemma.
    Moriette G; Mikaeloff Y; Jarreau PH; Desfrère L
    Pediatr Pulmonol Suppl; 1999; 18():209-11. PubMed ID: 10093145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between free T4 levels and postnatal steroid therapy in preterm infants.
    Arai H; Goto R; Matsuda T; Takahashi T
    Pediatr Int; 2009 Dec; 51(6):800-3. PubMed ID: 19419509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exhaled nitric oxide in chronically ventilated preterm infants.
    Williams O; Bhat RY; Cheeseman P; Rafferty GF; Hannam S; Greenough A
    Arch Dis Child Fetal Neonatal Ed; 2004 Jan; 89(1):F88-9. PubMed ID: 14711866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac effects of a single course of antenatal betamethasone in preterm infants.
    Vural M; Yilmaz I; Oztunç F; Ilikkan B; Erginöz E; Perk Y
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F118-22. PubMed ID: 16332923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of dexamethasone on growth, mineral balance and bone mineralisation in preterm infants with chronic lung disease.
    Shrivastava A; Lyon A; McIntosh N
    Eur J Pediatr; 2000 May; 159(5):380-4. PubMed ID: 10834526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants.
    Papile LA; Tyson JE; Stoll BJ; Wright LL; Donovan EF; Bauer CR; Krause-Steinrauf H; Verter J; Korones SB; Lemons JA; Fanaroff AA; Stevenson DK
    N Engl J Med; 1998 Apr; 338(16):1112-8. PubMed ID: 9545359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased use of postnatal corticosteroids in extremely preterm infants without increasing chronic lung disease.
    Seth R; Gray PH; Tudehope DI
    Neonatology; 2009; 95(2):172-8. PubMed ID: 18776732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth effects of systemic versus inhaled steroids in chronic lung disease.
    Nicholl RM; Greenough A; King M; Cheeseman P; Gamsu HR
    Arch Dis Child Fetal Neonatal Ed; 2002 Jul; 87(1):F59-61. PubMed ID: 12091295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.